Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-01 @ 1:18 PM
Study NCT ID:
NCT03843632
Status:
COMPLETED
Last Update Posted:
2021-04-06
First Post:
2019-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-14
First Submit QC Date:
None
Study First Post Date:
2019-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-10
Results First Submit QC Date:
None
Results First Post Date:
2021-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-10
Last Update Post Date:
2021-04-06
Last Update Post Date Type:
ACTUAL